Epista Life Science is an IT services and consultancy firm assisting Life Science companies worldwide

Investment Thesis

  • The investment thesis is anchored in continued organic growth coupled with further internationalization via M&A.
  • Organic growth is to be driven by targeted value propositions towards all types of life science customers ranging from mature pharma companies to biotech start-ups.
  • M&A will be deployed to accelerate further international growth and a consolidation of similar niche focused IT services firms dedicated to the life science industry

Main Transformation Initiatives

  • Further develop the organization for international growth
  • Develop current service offerings
  • Complement organic growth by pursuing strategic acquisitions

Key Facts

Country Denmark

Headquarter Hørsholm

Acquired 2022-05

FSN Ownership 64%

Sales 2022 EUR 18m

CEO Klavs Esbjerg

Chairperson Per Kogut

Pointperson Nicholas Hjorth

Webpage www.epista.com

Norway (Visiting address)
Via Vika / Ruseløkkveien 30
0251 Oslo
+47 24 14 73 00


FSN Capital Partners AB
Birger Jarlsgatan 15
111 45 Stockholm
+46 85 450 39 30

Norway (Post address)
FSN Capital Partners AS
PO. Box 1597
0118 Oslo


FSN Capital Partners GmbH
Maximiliansplatz 5
80333 Munich
+49 160 3666 627

FSN Capital Partners Aps
Kongens Nytorv 26, 2. Sal
1050 Copenhagen
+45 33 13 48 00